Nachrichten zur Johnson Matthey PLC Aktie

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its…

Abbott plans to weather tariff storm with investments in global manufacturing network

Like Johnson & Johnson did during its earnings call the day before, Abbott estimated that global tariffs would end up…

ETFs in Focus Post JNJs Q1 Earnings Beat, Dividend Hike

Johnson & Johnson reports strong first-quarter 2025 results, raises revenue guidance and boosts its quarterly dividends.…

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ

Johnson & Johnson (JNJ) and Albertsons Companies (ACI) stock have provided a pleasant hedge against market volatility and were able…

These 3 stocks in the news on Tuesday have trading potential, Jeff Kilburg says

Jeff Kilburg, founder and CEO of KKM Financial, discussed Netflix, Johnson & Johnson and Under Armour on CNBCs "Power Lunch."…

How J&J Is Navigating Tariffs and Investing in US Manufacturing

During the companys first-quarter earnings call, Johnson & Johnson executives addressed the challenges posed by $400 million in tariffs, primarily…

Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript

…

Stocks making the biggest moves premarket: Bank of America, Boeing, Johnson & Johnson and more

These are the stocks posting the largest moves in premarket trading.…

J&J’s Spravato momentum points to commercial viability of psychedelics for mental health, analysts say

Another quarter of consistent growth for Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray Spravato bodes well for other psychedelics, analysts…

Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves

…

Johnson & Johnson Aktie: Q1-Ergebnisse überraschen, aber die Aktien fallen

Frankfurt (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von XTB: Die Experten von XTB nehmen die Aktie von Johnson & Johnson (J&J) (ISIN:…

Johnson & Johnson Aktie: Zollbedingt Gewinnanpassung

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Compared to Estimates, Johnson & Johnson (JNJ) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in…

Dow Giant J&J Skids Despite Beat-And-Raise

Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its sales outlook.…

Band of America and Netflix rise premarket; Johnson & Johnson falls By Investing.com

Band of America and Netflix rise premarket; Johnson & Johnson falls…

J&J beats Wall Street quarterly sales and profit estimates on cancer drug sales

Johnson & Johnson on Tuesday reported first-quarter revenue and profit above Wall Street estimates, driven again by strong sales of…

Johnson & Johnson tops Q1 expectations, lifts 2025 sales outlook

Johnson & Johnson (NYSE:JNJ) reported its first quarter earnings, with both revenue and profit beating Wall Street expectations driven by…

US Futures Dip Ahead of Key Corporate Earnings

US stock futures edged lower on Tuesday as investors awaited earnings results from major firms, including Johnson & Johnson, Bank…

JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview

JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview…

Jim Cramers week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix

CNBCs Jim Cramer on Friday told investors which market-moving events to follow next week.…

Johnson & Johnson: Fairly Valued, But Recession-Resilient

…

Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D

On the heels of similar investment pledges by Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to…

Johnson & Johnson (JNJ) Stock Moves -0.52%: What You Should Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $149.83, marking a -0.52% move from the previous day.…

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Johnson & Johnson (JNJ) settling at $155.36, representing a +1.38% change from its previous close.…

NMAX, WTF, JNJ, HIMS, TSLA: Top 5 Trending Stocks Today - Hims & Hers Health (NYSE:HIMS), Johnson & Johnson (NYSE:JNJ)

U.S. stocks closed higher on Tuesday, with the Nasdaq Composite climbing 0.9% to 17,449.89. The S&P 500 added nearly 0.4%,…

Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback

Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day,…

Johnson & Johnson Aktie: Babypuder-Prozess belastet - Kurs bricht ein

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Markus Bußler vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Johnson &…

Warten auf das Zollpaket: Dow kaum verändert - Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Warten auf das Zollpaket: Dow kaum verändert – Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Warten auf das Zollpaket: Dow kaum verändert – Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (JohnsonJohnson) (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

dpa-AFX-Überblick: UNTERNEHMEN vom 01.04.2025 - 15.15 Uhr

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt NEW BRUNSWICK - Der US-Konzern Johnson & Johnson…

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder…

Stocks making the biggest moves premarket: PVH, Johnson & Johnson, Newsmax, Shake Shack and more

These are the stocks posting the largest moves in premarket trading.…

Johnson & Johnson shares fall as US judge rejects $10B talc settlement plan

Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal…

J&J shares fall after judge rejects $10 billion talc settlement

Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April

…

3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case By Reuters

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

A federal judge ordered Janssen to pay $1.64 billion after a jury found it liable in a whistleblower lawsuit for…

Deutsche Bank belässt Astrazeneca auf Hold - Ziel 11000 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.…

Johnson & Johnson to invest more than $55bn in US over next four years

The commitment marks a 25% increase to the companys US investments in the past four years…

List of companies pledging to invest billions in US since Donald Trump win

Trump has brought in some big investments in his two months in office, most recently Johnson & Johnson.…

J&J touts $55B in planned US investments over 4 years, including 3 new manufacturing sites

Johnson & Johnson says it will s | Johnson & Johnson will invest $55 billion in the U.S. over the…

J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday.…